Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture.
2019Scientific reports
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
candidateweakmoderate inflation risk
Coprococcus
atopic dermatitis
Coprococcus is an interesting but still moderate-confidence signal in atopic dermatitis.
Coprococcus currently has limited structured evidence in atopic dermatitis within this first-pass atlas build.
coprococcus
Credibility score
10
Human translation
4/5
Reproducibility
2/5
Novelty
5/5
Actionability
1/5
Credibility 10Human translation 4/5Reproducibility 2/5Novelty 5/5Actionability 1/5
Why this scores the way it does
- limited structured evidence volume
Main caveats
- limited central evidence
Primary central evidence
4 papersDupilumab therapy improves gut microbiome dysbiosis and tryptophan metabolism in Chinese patients with atopic dermatitis.
2024International immunopharmacology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Washed microbiota transplantation relieves atopic dermatitis via gut-skin microbiome rebalancing.
2026BMC microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Gut microbial IgA coating in infants with traditional farming lifestyle and urban infants with allergic outcomes.
2026Frontiers in immunology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Preclinical supporting evidence
1 papersSeverity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria.
2015Allergy
Disease-relevant preclinical or model-based paper useful as supporting evidence.